Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.
<h4>Objective</h4>Inflammatory bowel disease (IBD) is commonly treated with thiopurines such as azathioprine and mercaptopurine for the maintenance of remission. Studies examining chemopreventive of these medications on colorectal neoplasm in IBD patients have yielded conflicting results...
Enregistré dans:
Auteurs principaux: | Jianfeng Gong, Lijing Zhu, Zhen Guo, Yi Li, Weiming Zhu, Ning Li, Jieshou Li |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/df9b2eb1f85e470188f06a04de9ed493 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
par: Kanyarat Khaeso, et autres
Publié: (2021) -
Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma
par: Young Ae Cho, et autres
Publié: (2018) -
The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
par: Patrycja Kłos, et autres
Publié: (2021) -
Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data
par: Molly Pratt, et autres
Publié: (2021) -
Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series
par: Min Jee Kim, et autres
Publié: (2021)